StockData
Rezolute, Inc. logo

Rezolute, Inc. (RZLT) stock

RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$4.01+0.43 (+12.15%)

Close on Nov 17, 2026Market cap $388.34MP/E –Yield –

Rezolute EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Rezolute

Rezolute has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Rezolute figures

See a number that looks wrong?